Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for OrthoPediatrics Corp. (KIDS : NSDQ)

• Company Description    OrthoPediatrics Corp. is a medical device company. It markets surgical systems for trauma and deformity, bone fractures and reconstruction procedures. OrthoPediatrics Corp. is based in NEW YORK. Number of Employees: 133

• Price / Volume Information    Yesterday's Closing Price: $42.11 Daily Weekly Monthly 20 Day Moving Average: 135,441 shares Shares Outstanding: 20.23 (millions) Market Capitalization: $851.88 (millions) Beta: 0.88 52 Week High: $73.91 52 Week Low: $36.71 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -13.62% -5.71% 12 Week -14.76% -7.87% Year To Date -29.65% -16.67%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2850 Frontier Drive - Warsaw,IN 46582 USA ph: 574-268-6379 fax: 574-269-3692 tbui@theruthgroup.com http://www.orthopediatrics.com

• General Corporate Information    Officers David R. Bailey - President and Chief Executive Officer Fred L. Hite - Chief Financial Officer and Chief Operating Office Mark C. Throdahl - Director Bryan W. Hughes - Director Terry D. Schlotterback - Director Peer Information OrthoPediatrics Corp. (ABMD) OrthoPediatrics Corp. (DMDS) OrthoPediatrics Corp. (CPWY.) OrthoPediatrics Corp. (EQUR) OrthoPediatrics Corp. (ECIA) OrthoPediatrics Corp. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 68752L100 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/03/22 Share - Related Items Shares Outstanding: 20.23 Most Recent Split Date: (:1) Beta: 0.88 Market Capitalization: $851.88 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.14 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.79 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/03/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.68 Price/Cash Flow: - Price / Sales: 8.52 EPS Growth vs. Year Ago Period: -20.00% vs. Previous Quarter: -25.00% Sales Growth vs. Year Ago Period: 9.11% vs. Previous Quarter: -5.63% ROE 03/31/22 - -6.98 12/31/21 - -6.54 09/30/21 - -7.10 ROA 03/31/22 - -5.10 12/31/21 - -4.74 09/30/21 - -5.13 Current Ratio 03/31/22 - - 12/31/21 - 4.50 09/30/21 - 4.83 Quick Ratio 03/31/22 - - 12/31/21 - 2.56 09/30/21 - 2.86 Operating Margin 03/31/22 - -15.55 12/31/21 - -14.85 09/30/21 - -17.32 Net Margin 03/31/22 - -14.98 12/31/21 - -16.58 09/30/21 - -32.93 Pre-Tax Margin 03/31/22 - - 12/31/21 - -17.73 09/30/21 - -34.68 Book Value 03/31/22 - - 12/31/21 - 11.45 09/30/21 - 11.24 Inventory Turnover 03/31/22 - - 12/31/21 - 0.44 09/30/21 - 0.39 Debt-to-Equity 03/31/22 - - 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - - 12/31/21 - 0.40 09/30/21 - 0.42

Powered by Zacks Investment Research ©